Allarity Therapeutics News

Allarity Therapeutics | 8-K: Current report

Nov 19 08:06 ET

Allarity Therapeutics | 10-Q: Q3 2024 Earnings Report

Nov 14 16:25 ET

Allarity Therapeutics | 8-K: Allarity Therapeutics Reports Third Quarter 2024 Financial Results and Provides Recent Operational Highlights

Nov 14 08:21 ET

Allarity Therapeutics | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-3i, LP(0%),3i Management LLC(0%), etc.

Nov 13 21:28 ET

Allarity Therapeutics | 8-K: Current report

Oct 23 08:05 ET

Allarity Therapeutics | 8-K: Current report

Oct 11 08:03 ET

Allarity Therapeutics | 8-K: Current report

Oct 4 08:04 ET

Allarity Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Graff Jeremy R.

Oct 1 17:35 ET

Allarity Therapeutics | 3: Initial statement of beneficial ownership of securities-Officer Graff Jeremy R.

Oct 1 17:35 ET

Allarity Therapeutics | 3: Initial statement of beneficial ownership of securities-Officer Epshinsky Alexander

Sep 18 16:08 ET

Allarity Therapeutics | 8-K: Current report

Sep 17 08:04 ET

Allarity Therapeutics | 8-K: Current report

Sep 13 08:56 ET

Allarity Therapeutics | 8-K/A: Current report (Amendment)

Sep 10 09:18 ET

Allarity Therapeutics | 424B5: Prospectus

Sep 9 16:06 ET

Allarity Therapeutics | 8-K: Current report

Sep 9 09:05 ET

Allarity Therapeutics | S-3: Registration statement for specified transactions by certain issuers

Aug 30 16:08 ET

Allarity Therapeutics | SCHEDULE 13G: Others

Aug 29 18:01 ET

Allarity Therapeutics | SC 13G: Statement of acquisition of beneficial ownership by individuals-Streeterville Capital LLC(14.7%),Streeterville Management LLC(14.7%), etc.

Aug 29 16:01 ET

Allarity Therapeutics | 8-K: Current report

Aug 21 17:00 ET

Allarity Therapeutics | DEFR14A: Definitive proxy statement in connection with contested solicitations

Aug 20 12:52 ET